SYMPATHOMIMETIC AMINES have been
shown to alter cardiovascular hemodynamics in experimental conditions,1-4in normal man,5 8 and in patients in shock,9 12 but the effects of the various drugs may differ considerably according to the speciflc conditions under which they were observed. Moreover, individual differences in the responses to the various agents within various groups of shock patients are to be expected. Presumably the type of shock, initiating factors, duration of shock and physiological alterations of the shock state may affect the character and magnitude of responses to exogenous administration of catecholamines.11 Further, individual differences in responses may render evaluation of various therapeutic regimens in different groups of patients exceedingly difficult.
The present study was undertaken to compare the effects of four catecholamines on a series of 17 patients in various degrees of shock. The experimental protocol was designed to provide maximum comparability between the agents studied. Each agent was administered separately and in randomized sequence, the patient serving as his own control.
Group Studied and Methods

Clinical Material
Hemodynamic responses to four sympathomimetic amines were compared in a series of 17 patients who were in a state of shock. Patients were considered to be in severe shock if their clinical findings met the following criteria: sys- 15 cases, but in six of these it was complicated by sepsis. In two cases, sepsis was felt to be the initiating factor leading to shock. Fifteen of the patients had received blood or colloid as volume replacement prior to this study, and all patients were normovolemic. Prior to the observations, administration of pressor agents was discontinued for those patients to whom they had been given, and the vital signs were allowed to stabilize prior to hemodynamic measurements. The clinical data are summarized in table 1.
Methods and Techniques
Sympathomimetic amines were given in randomized sequence over a period of approximately 30 minutes or until steady conditions were observed. Between administration of the separate agents, vital signs were permitted to return to control levels. Usually two or more measurements of cardiac output were made in the control period and a similar number were made during infusion of each drug. More 13 ,ug/kg/min, respectively, until vital signs became stabilized at new levels. Stabilization usually occurred within 2 or 3 minutes, and the infusion rate was then readjusted to maintain constant blood pressure and heart rate during hemodynamic measurements. In a few instances adjustments in doses of the vasopressors were made until arterial pressure responses were observed, or in the case of isoproterenol, until changes in heart rate were observed.
Results
Results of the hemodynamic measurements on 17 patients before and during infusion of sympathomimetic amines are summarized in cardiac output significantly. Obviously, tabulation of mean values and routine statistical analysis of the data are not expected to be helpful in understanding the reasons for the wide variations in individual responses nor the mechanisms responsible for the action of each agent. Furthermore, the standard comparisons of patients grouped according to the agent administered may not be the most fruitful approach to understanding these problems.
The responses of individual patients to methoxamine administration were used to discern patterns of change which might be attributed to a common physiological mechanism. Obvious difficulties in interpretation arise when considering agents which exert simultaneous cardiac and peripheral effects. However, interpretation of the response to methoxamine is simplified because this agent is thought to exert its principal effect on the peripheral vasculature, there being no evidence of a direct action on the heart. According to criteria defined by Brewster and co-workers,'4 responses to methoxamine may be: (a) normal responses which consist of increased blood pressure, peripheral resistance, central blood volume, stroke work, and cardiac work; and (b) adverse responses which consist of increased peripheral resistance with failure to increase the other modalities.
Six of the shock patients given methoxamine had hemodynamic responses similar to those described in normal patients. 5 Although those patients had been in severe shock, their shock was considered less severe than that of the patients who responded poorly to methoxamine. These data are summarized in table 3. In this group of patients with favorable methoxamine responses, norepinephrine and metaraminol produced response patterns which were qualitatively similar to that of methoxamine. In constrast to the other agents, isoproterenol infusion markedly increased cardiac output and decreased peripheral resistance in this group.
The remaining five patients responded poorly to methoxamine; the changes produced Circulation, Volume XXXIV, August 1966 may be described as deterioration of all hemodynamic modalities (table 4) . Blood pressure was not significantly increased; stroke volume and cardiac output were moderately decreased. Central blood volume, stroke work, and cardiac work also decreased, but peripheral resistance increased moderately. In this group with adverse responses to methoxamine, the pattern of deterioration was reversed with norepinephrine and metaraminol infusion; the change was most pronounced with the former. Norepinephrine infusion significantly increased systemic pressure, total peripheral resistance, central blood volume, stroke work, and cardiac work. In this same group, metaraminol significantly increased central venous pressure and central blood volume. Isoproterenol increased cardiac output in most of these patients; this increase was not significant from a statistical point of view, probably because of the small number of patients involved. Discussion
Hemodynamic responses to four amines were compared in the same series of shock patients. Only isoproterenol produced marked and highly significantly increased cardiac output. Irrespective of these individual variations, isoproterenol was the most effective agent favorably affecting cardiovascular modalities.
Each of the agents used in this study significantly increased cardiac work and systemic pressure. Arterial pressure has been considered to be the resultant of dynamic interrelationships of multiple variables; two of these are flow and resistance.'5 If other variables remain constant, elevations in arterial pressure may be associated with increased cardiac output or increased resistance or both. Cardiac work also may be an expression of several factors; it may represent the work performed in moving blood through the cardiovascular system or it may reflect the work expended in overcoming peripheral resistance. The infusion of each of the four agents to patients in this series resulted in significantly increased cardiac work. Total peripheral resistance increased significantly during infusion The presence of limited ventricular reserve and relative refractoriness to catecholamine stimulation in patients in severe shock may be appreciated by considering the mechanisms operative during methoxamine infusion. Presumably, venous constriction during methoxamine infusion produced elevation of central venous pressure, increased right heart filling pressure, and increased central blood volume. Increased central blood volume may be construed to be an indirect index of the capacity of the right heart to respond to increased venous pressure by transferring blood from the peripheral to the pulmonary circulation at increased rates. The secondary effects of elevated systemic pressure probably are responsible for the slight increase in stroke volume normally observed during administration of methoxamine. Increased fiber length may result from prolonged diastolic filling, when the heart rate is slowed reflexly during pressure elevation. This is consistent with the finding of Harrison and associates7 who observed increased end-diastolic fiber length in normal human subjects given methoxamine. According to the Frank-Starling hypothesis, normally responding hearts react to an increase in fiber length or filling pressure by increasing the force of ventricular contraction. Figure 1 Representative ventricular function curves for the normal heart, the failing heart, and the heart after infusion of epinephrine. (After Sarnoff and Berglund.16) in a schematic manner an interpretation of the data. According to this system, increased endogenous secretion or exogenous administration of catecholamines results in greater stroke work per unit increase of filling pressure or fiber length and, thus, shifts the curve to the left. Presumably, those patients who developed increased stroke work during methoxamine infusion are by definition operating on portions of ventricular function curves which lie between the normal range and the points of maximal cardiac output. In the failing heart, increased fiber length or filling pressure is accompanied by little or no increase in ventricular stroke work. The patients who had adverse responses to methoxamine infusion are considered to be operating on failure curves which by definition lie to the right of, and below, the configuration of a "normal" curve ( fig. 1) . Evidence for the latter conclusion lies in two indirect indices of right and left ventricular failure; namely, decreased central blood volume and inability to increase left ventricular stroke work significantly during methoxamine infusion. Because left atria] pressures were not directly measured in our patients, the exact configuration of the function curve in each patient cannot be determined from the data.
Those patients who responded poorly to methoxamine infusion developed responses suggestive of relative ventricular decompensation. However, these patients were able to generate increased stroke work, when given agents with inotropic as well as pressor effects. Moreover, the tendency toward decreased central blood volume during methoxamine infusion in this group was reversed by norepinephrine and metaraminol. The latter two agents significantly increased central blood volume in the patients who did not respond to methoxamine.
Two conclusions may be drawn from results of studies on patients who responded poorly to methoxamine. Firstly, even in terminal stages of shock, the heart usually is not absolutely refractory to catecholamine stimulation; it responded to norepinephrine and metaraminol infusiQn with increased central blood volume and ventricular stroke work. Secondly, reversal of methoxamine-induced decompensation by inotropic agents may be considered in terms of a shift of the function curve to the left, that is, toward maximum theoretical cardiac performance ( fig. 1) . The shift of the function curve in these patients may be the result of two phenomena: direct inotropic drug effect or improved coronary perfusion at higher levels of mean arterial pressure. 17 The latter hypothesis cannot be directly confirmed by the data in this study.
Hemodynamic deterioration observed during methoxamine infusion was based on a limited number of individual responses in patients who fell into this category. In the course of this investigation, we realized that administration of a "pure" pressor agent may produced the hemodynamic changes characteristic of ventricular failure in some shock patients. This observation recently has been reported by Gunnar Individual patient responses were analyzed in terms of their response to methoxamine. Hemodynamic changes characteristic of ventricular failure were observed in four patients who received methoxamine. Reversal of this pattern of ventricular failure was noted during infusion of agents with an inotropic effect. A hypothesis which explains these hemodynamic changes is discussed.
